VivoSeq
Other

Elevated Cholesterol

0

Pipeline Programs↗

0

Active Trials↗

2

Companies Involved↗

Elevated Cholesterol is an early-stage landscape with 0 programs across 2 companies. The most active players are Takeda, Novartis.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Takeda logo

Takeda

0 programs

PreclinicalNovartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed5 · 100%

Clinical Trials

Trial Activity

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
Completed·Takeda logoTakeda·Phase 3·NCT00143663·361 enrolled
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)
Completed·MMitsukoshi Health and Welfare Foundation·Phase 4·NCT00211705·8,000 enrolled
Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)
Completed·—·Phase 3·NCT00090298·2,815 enrolled
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
Completed·Novartis logoNovartis·Phase 1·NCT01859455·25 enrolled
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00046267·30 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)